The AWS grant will enable Arine’s proprietary technology platform to build solutions for vulnerable populations

SAN FRANCISCO, April 28, 2022 /PRNewswire/ — Arine, an intelligent medication optimization company, announced today that it has been selected for Amazon Web Services (AWS). 40 million dollars global program to support organizations developing solutions to reduce health inequities. Arine’s proprietary AI-driven platform ensures safe and effective drug therapy by synthesizing multidimensional data to develop personalized drug recommendations for vulnerable patient populations, including elderly, low-income and under-represented patients.

through the program, AWS provides credit and technical expertise to organizations around the world that use AWS to improve health outcomes and equity in any of the following areas: 1) Improving access to health services for underserved communities; 2) Addressing social determinants of health (SDoH) as a barrier…

Source link

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.